AAAAAA
Results: 1-25/38
Authors:
Balasch, J
Creus, M
Fabregues, F
Civico, S
Carmona, F
Puerto, B
Casamitjana, R
Vanrell, JA
Citation: J. Balasch et al., The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction, J AS REPROD, 18(5), 2001, pp. 250-256
Authors:
Balasch, J
Barri, PN
Citation: J. Balasch et Pn. Barri, Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective, J AS REPROD, 18(2), 2001, pp. 45-55
Authors:
Carmona, F
Font, J
Azulay, M
Creus, M
Fabregues, F
Cervera, R
Puerto, B
Balasch, J
Citation: F. Carmona et al., Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis, AM J REPROD, 46(4), 2001, pp. 274-279
Authors:
Balasch, J
Vidal, E
Penarrubia, J
Casamitjana, R
Carmona, F
Creus, M
Fabregues, F
Vanrell, JA
Citation: J. Balasch et al., Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH, HUM REPR, 16(8), 2001, pp. 1636-1643
Authors:
Creus, M
Ordi, J
Fabregues, F
Casamitjana, R
Vanrell, JA
Balasch, J
Citation: M. Creus et al., Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation, HUM REPR, 16(7), 2001, pp. 1347-1352
Authors:
Balasch, J
Fabregues, F
Creus, M
Puerto, B
Penarrubia, J
Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens, HUM REPR, 16(4), 2001, pp. 652-656
Authors:
Tur, R
Barri, PN
Coroleu, B
Buxaderas, R
Martinez, F
Balasch, J
Citation: R. Tur et al., Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre, HUM REPR, 16(10), 2001, pp. 2124-2129
Authors:
Callejo, J
Salvador, C
Miralles, A
Vilaseca, S
Lailla, JM
Balasch, J
Citation: J. Callejo et al., Long-term ovarian function evaluation after autografting by implantation with fresh and frozen-thawed human ovarian tissue, J CLIN END, 86(9), 2001, pp. 4489-4494
Authors:
Balasch, J
Fabregues, F
Creus, M
Casamitjana, R
Puerto, B
Vanrell, JA
Citation: J. Balasch et al., Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol, J AS REPROD, 17(10), 2000, pp. 561-565
Authors:
Fabregues, F
Balasch, J
Creus, M
Carmona, F
Puerto, B
Quinto, L
Casamitjana, R
Vanrell, JA
Citation: F. Fabregues et al., Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome, J AS REPROD, 17(1), 2000, pp. 13-19
Authors:
Balasch, J
Fabregues, F
Creus, M
Penarrubia, J
Vidal, E
Carmona, F
Puerto, B
Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential, J AS REPROD, 17(1), 2000, pp. 20-27
Authors:
Munoz-Rodriguez, FJ
Reverter, JC
Font, J
Tassies, D
Cervera, R
Espinosa, G
Carmona, F
Balasch, J
Ordinas, A
Ingelmo, M
Citation: Fj. Munoz-rodriguez et al., Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome, HAEMATOLOG, 85(6), 2000, pp. 632-637
Authors:
Castelo-Branco, C
Vicente, JJ
Figueras, F
Sanjuan, A
de Osaba, MJM
Casals, E
Pons, F
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women, MATURITAS, 34(2), 2000, pp. 161-168
Authors:
Ballesca, JL
Balasch, J
Calafell, JM
Alvarez, R
Fabregues, F
de Osaba, MJM
Ascaso, C
Vanrell, JA
Citation: Jl. Ballesca et al., Serum inhibin B determination is predictive of successful testicular spermextraction in men with non-obstructive azoospermia, HUM REPR, 15(8), 2000, pp. 1734-1738
Authors:
Penarrubia, J
Balasch, J
Fabregues, F
Carmona, F
Casamitjana, R
Moreno, V
Calafell, JM
Vanrell, JA
Citation: J. Penarrubia et al., Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment, HUM REPR, 15(7), 2000, pp. 1499-1504
Authors:
Penarrubia, J
Balasch, J
Garcia-Bermudez, M
Casamitjana, R
Vanrell, JA
Hernandez, ER
Citation: J. Penarrubia et al., Growth hormone does not increase the expression of insulin-like growth factors and their receptor genes in the pre-menopausal human ovary, HUM REPR, 15(6), 2000, pp. 1241-1246
Authors:
Manau, D
Balasch, J
Jimenez, W
Fabregues, F
Civico, S
Casamitjana, R
Creus, M
Vanrell, JA
Citation: D. Manau et al., Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response, HUM REPR, 15(6), 2000, pp. 1295-1299
Authors:
Balasch, J
Reverter, JC
Citation: J. Balasch et Jc. Reverter, Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients, HUM REPR, 15(4), 2000, pp. 977-978
Authors:
Balasch, J
Citation: J. Balasch, Investigation of the infertile couple - Investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal, HUM REPR, 15(11), 2000, pp. 2251-2257
Authors:
Creus, M
Penarrubia, J
Fabregues, F
Vidal, E
Carmona, F
Casamitjana, R
Vanrell, JA
Balasch, J
Citation: M. Creus et al., Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome, HUM REPR, 15(11), 2000, pp. 2341-2346
Authors:
Out, HJ
Braat, DDM
Lintsen, BME
Gurgan, T
Bukulmez, O
Gokmen, O
Keles, G
Caballero, P
Gonzalez, JM
Fabregues, F
Balasch, J
Roulier, R
Citation: Hj. Out et al., Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation, HUM REPR, 15(1), 2000, pp. 29-35
Authors:
Balasch, J
Citation: J. Balasch, The challenge of meta-analysis and the need to register clinical trials, FERT STERIL, 74(2), 2000, pp. 420-420
Authors:
Fabregues, F
Balasch, J
Manau, D
Creus, M
Jimenez, W
Carmona, F
Casamitjana, R
Vanrell, JA
Citation: F. Fabregues et al., Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone, ACT OBST SC, 79(7), 2000, pp. 564-569
Authors:
Castelo-Branco, C
Figueras, F
Sanjuan, A
Vicente, JJ
de Osaba, MJM
Pons, F
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: Benefits to bone and analysis of factors associated with discontinuation, MENOPAUSE, 6(4), 1999, pp. 307-311
Authors:
Castelo-Branco, C
Casals, E
Figueras, F
Sanjuan, A
Vicente, JJ
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B, MENOPAUSE, 6(2), 1999, pp. 92-97